Table 2 |
||||||||
|
Comparison of the overall mutational frequencies of VH rearrangements obtained from individual peripheral CD19+ (CD27- or CD27+) B cells of rheumatoid arthritis patient A before therapy and 7 months after first therapy |
||||||||
|
Before therapy |
7 months after therapy |
|||||||
|
|
||||||||
|
n |
Mutations (n) |
Total bp |
Mutational frequency (%) |
n |
Mutations (n) |
Total bp |
Mutational frequency (%) |
|
|
|
||||||||
|
CD19+CD27- |
18 |
27 |
4,349 |
0.62 |
15 |
183 |
3,443 |
5.31* |
|
CD19+CD27+ |
Not determined |
22 |
477 |
5,745 |
8.30 |
|||
|
|
||||||||
|
* P < 0.0001 versus before therapy using chi-square test. |
||||||||
|
Rouzière et al. Arthritis Research & Therapy 2005 7:R714 doi:10.1186/ar1731 |
||||||||